The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| 89BIO INC | COM | 282559103 | 20,215,557 | 1,066,784 | SH | SOLE | 1,066,784 | 0 | 0 | |||
| AEROVATE THERAPEUTICS INC | COM | 008064107 | 10,662,361 | 621,712 | SH | SOLE | 621,712 | 0 | 0 | |||
| ALPINE IMMUNE SCIENCES INC | COM | 02083G100 | 7,710,000 | 750,000 | SH | SOLE | 750,000 | 0 | 0 | |||
| AN2 THERAPEUTICS INC | COM | 037326105 | 6,127,650 | 720,900 | SH | SOLE | 720,900 | 0 | 0 | |||
| ANNEXON INC | COM | 03589W102 | 5,843,200 | 1,660,000 | SH | SOLE | 1,660,000 | 0 | 0 | |||
| APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 238,527,130 | 2,618,300 | SH | SOLE | 2,618,300 | 0 | 0 | |||
| ARCUS BIOSCIENCES INC | COM | 03969F109 | 39,970,080 | 1,968,000 | SH | SOLE | 1,968,000 | 0 | 0 | |||
| BRIDGEBIO PHARMA INC | COM | 10806X102 | 20,970,240 | 1,219,200 | SH | SOLE | 1,219,200 | 0 | 0 | |||
| CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 25,783,339 | 759,898 | SH | SOLE | 759,898 | 0 | 0 | |||
| CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | 152309100 | 2,549,834 | 411,928 | SH | SOLE | 411,928 | 0 | 0 | |||
| CYMABAY THERAPEUTICS INC | COM | 23257D103 | 50,051,552 | 4,570,918 | SH | SOLE | 4,570,918 | 0 | 0 | |||
| DISC MEDICINE INC | COM | 254604101 | 18,426,000 | 415,000 | SH | SOLE | 415,000 | 0 | 0 | |||
| DYNE THERAPEUTICS INC | COM | 26818M108 | 7,795,631 | 692,945 | SH | SOLE | 692,945 | 0 | 0 | |||
| GERON CORP | COM | 374163103 | 7,312,380 | 2,278,000 | SH | SOLE | 2,278,000 | 0 | 0 | |||
| GLYCOMIMETICS INC | COM | 38000Q102 | 5,220,000 | 3,000,000 | SH | SOLE | 3,000,000 | 0 | 0 | |||
| GOSSAMER BIO INC | COM | 38341P102 | 4,749,683 | 3,958,069 | SH | SOLE | 3,958,069 | 0 | 0 | |||
| HEPION PHARMACEUTICALS INC | COM NEW | 426897302 | 1,627,500 | 155,000 | SH | SOLE | 155,000 | 0 | 0 | |||
| INOZYME PHARMA INC | COM | 45790W108 | 276,840 | 49,702 | SH | SOLE | 49,702 | 0 | 0 | |||
| INSMED INC | COM PAR $.01 | 457669307 | 7,743,700 | 367,000 | SH | SOLE | 367,000 | 0 | 0 | |||
| ITEOS THERAPEUTICS INC | COM | 46565G104 | 7,891,040 | 596,000 | SH | SOLE | 596,000 | 0 | 0 | |||
| IVERIC BIO INC | COM | 46583P102 | 1,967,000 | 50,000 | SH | Put | SOLE | 50,000 | 0 | 0 | ||
| JASPER THERAPEUTICS INC | COM | 471871103 | 6,121,316 | 4,468,114 | SH | SOLE | 4,468,114 | 0 | 0 | |||
| LEXICON PHARMACEUTICALS INC | COM NEW | 528872302 | 4,403,844 | 1,923,076 | SH | SOLE | 1,923,076 | 0 | 0 | |||
| MAGENTA THERAPEUTICS INC | COM | 55910K108 | 416,900 | 550,000 | SH | SOLE | 550,000 | 0 | 0 | |||
| MIRATI THERAPEUTICS INC | COM | 60468T105 | 27,097,500 | 750,000 | SH | SOLE | 750,000 | 0 | 0 | |||
| MONTE ROSA THERAPEUTICS INC | COM | 61225M102 | 136,315 | 19,900 | SH | SOLE | 19,900 | 0 | 0 | |||
| ORIC PHARMACEUTICALS INC | COM | 68622P109 | 2,149,520 | 277,000 | SH | SOLE | 277,000 | 0 | 0 | |||
| PIERIS PHARMACEUTICALS INC | COM | 720795103 | 1,092,300 | 6,600,000 | SH | SOLE | 6,600,000 | 0 | 0 | |||
| PMV PHARMACEUTICALS INC | COM | 69353Y103 | 2,942,200 | 470,000 | SH | SOLE | 470,000 | 0 | 0 | |||
| RENEO PHARMACEUTICALS INC | COM | 75974E103 | 15,537,931 | 2,368,587 | SH | SOLE | 2,368,587 | 0 | 0 | |||
| ROIVANT SCIENCES LTD | SHS | G76279101 | 39,352,320 | 3,904,000 | SH | SOLE | 3,904,000 | 0 | 0 | |||
| STOKE THERAPEUTICS INC | COM | 86150R107 | 1,973,661 | 185,669 | SH | SOLE | 185,669 | 0 | 0 | |||
| STRUCTURE THERAPEUTICS INC | SPONSORED ADS | 86366E106 | 3,117,750 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | |||
| TANDEM DIABETES CARE INC | COM NEW | 875372203 | 11,654,758 | 474,929 | SH | SOLE | 474,929 | 0 | 0 | |||
| TRAVERE THERAPEUTICS INC | COM | 89422G107 | 7,603,200 | 495,000 | SH | SOLE | 495,000 | 0 | 0 | |||
| VERA THERAPEUTICS INC | CL A | 92337R101 | 1,123,500 | 70,000 | SH | SOLE | 70,000 | 0 | 0 | |||
| VERONA PHARMA PLC | SPONSORED ADS | 925050106 | 52,173,520 | 2,468,000 | SH | SOLE | 2,468,000 | 0 | 0 | |||
| VIKING THERAPEUTICS INC | COM | 92686J106 | 6,078,750 | 375,000 | SH | SOLE | 375,000 | 0 | 0 | |||
| VIR BIOTECHNOLOGY INC | COM | 92764N102 | 15,946,953 | 650,100 | SH | SOLE | 650,100 | 0 | 0 | |||
| VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 21,958,170 | 923,000 | SH | SOLE | 923,000 | 0 | 0 | |||
| XILIO THERAPEUTICS INC | COM | 98422T100 | 6,353,500 | 2,425,000 | SH | SOLE | 2,425,000 | 0 | 0 | |||